These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1344 related items for PubMed ID: 21745271

  • 1. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, Faraci G, Pacetti D, Vivarelli M, Nicolini D, Garelli P, Casini A, Manco M, Mingrone G, Risaliti A, Frega GN, Benedetti A, Gastaldelli A.
    Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
    [Abstract] [Full Text] [Related]

  • 2. Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice.
    Trevaskis JL, Griffin PS, Wittmer C, Neuschwander-Tetri BA, Brunt EM, Dolman CS, Erickson MR, Napora J, Parkes DG, Roth JD.
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr 15; 302(8):G762-72. PubMed ID: 22268099
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.
    J Gastroenterol Hepatol; 2012 Feb 15; 27(2):341-50. PubMed ID: 21929649
    [Abstract] [Full Text] [Related]

  • 4. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM.
    Food Chem Toxicol; 2014 Feb 15; 64():94-103. PubMed ID: 24275089
    [Abstract] [Full Text] [Related]

  • 5. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
    Burmeister MA, Ayala J, Drucker DJ, Ayala JE.
    Am J Physiol Endocrinol Metab; 2013 Apr 01; 304(7):E677-85. PubMed ID: 23341495
    [Abstract] [Full Text] [Related]

  • 6. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R.
    Obesity (Silver Spring); 2010 Apr 01; 18(4):780-7. PubMed ID: 19798065
    [Abstract] [Full Text] [Related]

  • 7. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model.
    Matsunami T, Sato Y, Ariga S, Sato T, Shimomura T, Kashimura H, Hasegawa Y, Yukawa M.
    Metabolism; 2011 Jun 01; 60(6):805-14. PubMed ID: 20846698
    [Abstract] [Full Text] [Related]

  • 8. Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway.
    Zhang W, Wu R, Zhang F, Xu Y, Liu B, Yang Y, Zhou H, Wang L, Wan K, Xiao X, Zhang X.
    Clin Exp Pharmacol Physiol; 2012 Dec 01; 39(12):1026-33. PubMed ID: 23127227
    [Abstract] [Full Text] [Related]

  • 9. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
    Kang OH, Kim SB, Mun SH, Seo YS, Hwang HC, Lee YM, Lee HS, Kang DG, Kwon DY.
    Int J Mol Med; 2015 Mar 01; 35(3):803-9. PubMed ID: 25605057
    [Abstract] [Full Text] [Related]

  • 10. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S.
    Gastroenterology; 2007 Jan 01; 132(1):282-93. PubMed ID: 17241878
    [Abstract] [Full Text] [Related]

  • 11. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN, Tao RY, Tian JY, Liu GT, Ye F.
    Life Sci; 2008 May 07; 82(19-20):983-90. PubMed ID: 18417155
    [Abstract] [Full Text] [Related]

  • 12. Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway.
    Gupta NA, Mells J, Dunham RM, Grakoui A, Handy J, Saxena NK, Anania FA.
    Hepatology; 2010 May 07; 51(5):1584-92. PubMed ID: 20225248
    [Abstract] [Full Text] [Related]

  • 13. Enhanced protection against cytokine- and fatty acid-induced apoptosis in pancreatic beta cells by combined treatment with glucagon-like peptide-1 receptor agonists and insulin analogues.
    Tews D, Werner U, Eckel J.
    Horm Metab Res; 2008 Mar 07; 40(3):172-80. PubMed ID: 18348079
    [Abstract] [Full Text] [Related]

  • 14. Dietary folic acid activates AMPK and improves insulin resistance and hepatic inflammation in dietary rodent models of the metabolic syndrome.
    Buettner R, Bettermann I, Hechtl C, Gäbele E, Hellerbrand C, Schölmerich J, Bollheimer LC.
    Horm Metab Res; 2010 Oct 07; 42(11):769-74. PubMed ID: 20803414
    [Abstract] [Full Text] [Related]

  • 15. [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease].
    Tan Y, Zhang JN, Chen JH, Wang LJ, Liu HX.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov 07; 17(11):821-5. PubMed ID: 19958640
    [Abstract] [Full Text] [Related]

  • 16. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
    Baggio LL, Huang Q, Cao X, Drucker DJ.
    Gastroenterology; 2008 Apr 07; 134(4):1137-47. PubMed ID: 18313669
    [Abstract] [Full Text] [Related]

  • 17. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
    Burmeister MA, Ferre T, Ayala JE, King EM, Holt RM, Ayala JE.
    Am J Physiol Endocrinol Metab; 2012 Feb 01; 302(3):E334-43. PubMed ID: 22094469
    [Abstract] [Full Text] [Related]

  • 18. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury.
    Svegliati-Baroni G, Candelaresi C, Saccomanno S, Ferretti G, Bachetti T, Marzioni M, De Minicis S, Nobili L, Salzano R, Omenetti A, Pacetti D, Sigmund S, Benedetti A, Casini A.
    Am J Pathol; 2006 Sep 01; 169(3):846-60. PubMed ID: 16936261
    [Abstract] [Full Text] [Related]

  • 19. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T.
    Breast Cancer Res Treat; 2012 Apr 01; 132(2):449-61. PubMed ID: 21638053
    [Abstract] [Full Text] [Related]

  • 20. Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms.
    Ji G, Yang Q, Hao J, Guo L, Chen X, Hu J, Leng L, Jiang Z.
    Int Immunopharmacol; 2011 Jun 01; 11(6):762-8. PubMed ID: 21320636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.